Literature DB >> 17380063

Laser treatment in diabetic retinopathy.

Aljoscha S Neubauer1, Michael W Ulbig.   

Abstract

Diabetic retinopathy is a leading cause of visual impairment and blindness in developed countries due to macular edema and proliferative diabetic retinopathy (PDR). For both complications laser treatment may offer proven therapy: the Diabetic Retinopathy Study demonstrated that panretinal scatter photocoagulation reduces the risk of severe visual loss by >50% in eyes with high-risk characteristics. Panretinal scatter coagulation may also be beneficial in other PDR and severe nonproliferative diabetic retinopathy (NPDR) under certain conditions. For clinically significant macular edema the Early Treatment of Diabetic Retinopathy Study could show that immediate focal laser photocoagulation reduces the risk of moderate visual loss by at least 50%. When and how to perform laser treatment is described in detail, offering a proven treatment for many problems associated with diabetic retinopathy based on a high evidence level. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17380063     DOI: 10.1159/000098254

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  16 in total

1.  [Navigated retinal laser therapy].

Authors:  M Kernt; M Ulbig; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

Review 2.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 3.  Navigated Laser Therapy for Diabetic Macular Oedema.

Authors:  Marcus Kernt; Michael Ulbig; Anselm Kampik; Aljoscha S Neubauer
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.

Authors:  Ahamed Hossain; David Heron; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Shusheng Wang; Partha S Bhattacharjee
Journal:  Exp Eye Res       Date:  2016-06-23       Impact factor: 3.467

5.  Diabetic Retinopathy and Laser Therapy in Rats: A Protein-Protein Interaction Network Analysis.

Authors:  Akram Safaei; Mostafa Rezaei Tavirani; Mona Zamanian Azodi; Alireza Lashay; Seyed Farzad Mohammadi; Mohamad Ghasemi Broumand; Ali Asghar Peyvandi; Farshad Okhovatian; Hassan Peyvandi; Mohammad Rostami Nejad
Journal:  J Lasers Med Sci       Date:  2017-08-29

6.  Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series.

Authors:  Pukhraj Rishi; Ekta Rishi; Lakshmi Kuniyal; Gaurav Mathur
Journal:  Oman J Ophthalmol       Date:  2012-05

7.  Monotherapy laser photocoagulation for diabetic macular oedema.

Authors:  Eliane C Jorge; Edson N Jorge; Mayra Botelho; Joyce G Farat; Gianni Virgili; Regina El Dib
Journal:  Cochrane Database Syst Rev       Date:  2018-10-15

8.  A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series.

Authors:  Vera K Schmit-Eilenberger
Journal:  Clin Ophthalmol       Date:  2015-05-04

9.  Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy.

Authors:  Paul M Titchenell; David A Antonetti
Journal:  Diabetes       Date:  2013-06       Impact factor: 9.461

10.  Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser.

Authors:  Aljoscha S Neubauer; Julian Langer; Raffael Liegl; Christos Haritoglou; Armin Wolf; Igor Kozak; Florian Seidensticker; Michael Ulbig; William R Freeman; Anselm Kampik; Marcus Kernt
Journal:  Clin Ophthalmol       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.